Recent Updates
Recently added Catalysts
INCY Positive Sentiment

Riassunto: I dati di Incyte verranno evidenziati in quattro rapide presentazioni orali al Congresso 2026 della European Society for Medical Oncology (ESMO) a supporto dell'impegno per migliorare i risultati nei tumori difficili da curare

Friday, July 17, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Incyte has announced that it will present data from its oncology portfolio at the 2026 European Society for Medical Oncology (ESMO) Congress in Madrid. The presentations will include findings from various programs aimed at enhancing treatment outcomes for challenging cancers. The congress is scheduled to take place from October 23 to 27, 2026.
Price reaction · baseline $117.49 (2026-07-17T18:54:00.000Z) · hit during market hours · 1 other INCY headline(s) in the window, move may be shared
day 0 close · peak
-0.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Incyte will present data from various oncology programs.
  • The presentations will occur at a prestigious European oncology congress.
  • The event aims to improve outcomes for difficult-to-treat cancers.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
2.4%
average across 15 past catalysts
Lead asset
Retifanlimab
Phase 1 · Unmethylated Glioblastoma

Full Press Release Details

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) oggi ha annunciato che presenterà i dati provenienti da vari programmi nel suo portafoglio oncologico in sei presentazioni al Congresso 2026 della European Society of Medical Oncology (ESMO), che si svolgerà a Madrid dal 23 al 27 ottobre 2026. Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodità del lettore e devono rinviare al te

Frequently Asked Questions

When will the ESMO 2026 Congress take place?

The ESMO 2026 Congress will be held from October 23 to 27, 2026.

What will Incyte present at ESMO 2026?

Incyte will present data from various programs in its oncology portfolio.

Where is the ESMO 2026 Congress located?

The congress will take place in Madrid, Spain.

What is the focus of Incyte's presentations?

The presentations aim to improve outcomes for difficult-to-treat cancers.

ShareAdd on Google
Tags: INCY Incyte ESMO 2026 oncology cancer treatment medical conference
Last updated: Jul 17, 2026

Biotech snapshot

Cash runway
$4536M liquidity · $0M/mo burn
Low dilution risk
Lead asset
RetifanlimabPhase 1
Unmethylated Glioblastoma →

Catalyst track record

+34%
best trade around INCY's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for INCY.

See every catalyst's timing & PoA →